@article{ref1,
title="Towards rational, evidence-based, and clinically relevant measures to determine improvement following treatment for alcohol use disorder",
journal="Alcoholism: clinical and experimental research",
year="2017",
author="Johnson, Bankole A.",
volume="41",
number="4",
pages="703-707",
abstract="This interesting paper by Witkiewitz and colleagues (Witkiewitz et al. 2017) calls for the need to create a more comprehensive scale to acknowledge and measure the naturally fluctuating levels of drinking among patients. As such, there is a dire need to unify, under a common instrument, a clinically meaningful endpoint measure to determine the efficacy of treatment for alcohol use disorder (AUD) for both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Such a homology would have the advantage that any treatment found efficacious in either of these influential and pioneering domains would be applicable to the other. This article is protected by copyright. All rights reserved.<br><br>This article is protected by copyright. All rights reserved.<p /> <p>Language: en</p>",
language="en",
issn="0145-6008",
doi="10.1111/acer.13341",
url="http://dx.doi.org/10.1111/acer.13341"
}